• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前沿研究:固有免疫系统可区分含有细菌与真核生物结构特征的RNA,这些特征能促使树突状细胞高水平分泌白细胞介素-12。

Cutting edge: innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cells.

作者信息

Koski Gary K, Karikó Katalin, Xu Shuwen, Weissman Drew, Cohen Peter A, Czerniecki Brian J

机构信息

Harrison Department of Surgical Research, Department of Surgery, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

J Immunol. 2004 Apr 1;172(7):3989-93. doi: 10.4049/jimmunol.172.7.3989.

DOI:10.4049/jimmunol.172.7.3989
PMID:15034009
Abstract

RNA derived from bacterial but not eukaryotic sources, when transfected into human monocyte-derived dendritic cell precursors, induces high-level IL-12 secretion in conjunction with dendritic cell maturation stimuli. In vitro-transcribed mRNA that mimics the structure of bacterial mRNA in the lack of a long 3'-poly(A) tail likewise induces IL-12 secretion, but this property is lost upon efficient enzymatic 3'-polyadenylation. Among other tested RNAs, only polyuridylic acid induced IL-12 p70. This RNA response phenomenon appears biologically distinct from the classically defined response to dsRNA. RNA-transfected APC also polarize T cells in an IL-12-dependent manner toward the IFN-gamma(high)IL-5 (low) Th1 phenotype, suggesting a link between the detection of appropriately structured RNA and the skewing of immune responses toward those best suited for controlling intracellular microbes. RNA structured to emulate bacterial patterns constitutes a novel vaccine strategy to engender polarized Th1-type immune responses.

摘要

源自细菌而非真核生物的RNA,转染到人单核细胞衍生的树突状细胞前体中时,与树突状细胞成熟刺激物一起诱导高水平的IL-12分泌。在缺乏长3'-聚腺苷酸尾的情况下模拟细菌mRNA结构的体外转录mRNA同样诱导IL-12分泌,但这种特性在有效的酶促3'-聚腺苷酸化后丧失。在其他测试的RNA中,只有聚尿苷酸诱导IL-12 p70。这种RNA反应现象在生物学上似乎与经典定义的对双链RNA的反应不同。RNA转染的抗原呈递细胞也以IL-12依赖的方式将T细胞极化为IFN-γ(高)IL-5(低)Th1表型,这表明检测到适当结构的RNA与免疫反应偏向于最适合控制细胞内微生物的反应之间存在联系。构建成模拟细菌模式的RNA构成了一种产生极化Th1型免疫反应的新型疫苗策略。

相似文献

1
Cutting edge: innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cells.前沿研究:固有免疫系统可区分含有细菌与真核生物结构特征的RNA,这些特征能促使树突状细胞高水平分泌白细胞介素-12。
J Immunol. 2004 Apr 1;172(7):3989-93. doi: 10.4049/jimmunol.172.7.3989.
2
Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4.当在成熟开始时给予刺激时,人单核细胞衍生的树突状细胞产生白细胞介素-12的能力最佳,并且白细胞介素-4可进一步增强这种能力。
J Immunol. 2001 Jan 1;166(1):633-41. doi: 10.4049/jimmunol.166.1.633.
3
Double-Stranded RNA Derived from Lactic Acid Bacteria Augments Th1 Immunity Interferon-β from Human Dendritic Cells.乳酸菌来源的双链 RNA 增强人树突状细胞的 Th1 免疫干扰素-β。
Front Immunol. 2018 Jan 23;9:27. doi: 10.3389/fimmu.2018.00027. eCollection 2018.
4
Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens.基于树突状细胞(DC)对细胞内病原体的保护作用依赖于DC衍生的白细胞介素-12,并且可以由分子定义的抗原诱导产生。
J Immunol. 2003 Mar 15;170(6):3171-9. doi: 10.4049/jimmunol.170.6.3171.
5
Attenuated expression of A20 markedly increases the efficacy of double-stranded RNA-activated dendritic cells as an anti-cancer vaccine.A20的表达减弱显著提高了双链RNA激活的树突状细胞作为抗癌疫苗的功效。
J Immunol. 2009 Jan 15;182(2):860-70. doi: 10.4049/jimmunol.182.2.860.
6
Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC.经体外CpG DNA激活的树突状细胞(DC)是宿主对细胞内病原体产生抵抗力的有效诱导剂,这种抵抗力独立于来自免疫DC的IL-12。
J Immunol. 2004 May 15;172(10):6281-9. doi: 10.4049/jimmunol.172.10.6281.
7
Ignition of the type 1 response to intracellular infection by dendritic cell-derived interleukin-12.树突状细胞衍生的白细胞介素-12引发对细胞内感染的1型反应。
Eur Cytokine Netw. 1998 Sep;9(3 Suppl):65-8.
8
Cutting edge: dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses.前沿:与微生物和蠕虫抗原共刺激的树突状细胞经历修饰成熟,将抗原分隔到不同的细胞内区室,并同时诱导微生物特异性Th1和蠕虫特异性Th2反应。
J Immunol. 2004 Feb 15;172(4):2016-20. doi: 10.4049/jimmunol.172.4.2016.
9
Innate immune responses in human monocyte-derived dendritic cells are highly dependent on the size and the 5' phosphorylation of RNA molecules.人源单核细胞来源的树突状细胞中的先天免疫反应高度依赖于 RNA 分子的大小和 5' 磷酸化。
J Immunol. 2011 Aug 15;187(4):1713-21. doi: 10.4049/jimmunol.1100361. Epub 2011 Jul 8.
10
RNA interference shows critical requirement for NF-kappa B p50 in the production of IL-12 by human dendritic cells.RNA干扰显示人树突状细胞产生白细胞介素-12过程中对核因子κB p50有关键需求。
J Immunol. 2003 Aug 15;171(4):1750-7. doi: 10.4049/jimmunol.171.4.1750.

引用本文的文献

1
LINE-1 RNA triggers matrix formation in bone cells via a PKR-mediated inflammatory response.LINE-1 RNA 通过 PKR 介导的炎症反应触发骨细胞中的基质形成。
EMBO J. 2024 Sep;43(17):3587-3603. doi: 10.1038/s44318-024-00143-z. Epub 2024 Jul 1.
2
Strategies to reduce the risks of mRNA drug and vaccine toxicity.降低 mRNA 药物和疫苗毒性风险的策略。
Nat Rev Drug Discov. 2024 Apr;23(4):281-300. doi: 10.1038/s41573-023-00859-3. Epub 2024 Jan 23.
3
The forerunners and successful partnerships behind the BioNTech mRNA vaccine.BioNTech mRNA 疫苗的先驱和成功合作伙伴。
J Appl Genet. 2024 Feb;65(1):47-55. doi: 10.1007/s13353-023-00793-5. Epub 2023 Oct 20.
4
Synthesis of point-modified mRNA.点修饰 mRNA 的合成。
Nucleic Acids Res. 2022 Nov 11;50(20):e115. doi: 10.1093/nar/gkac719.
5
The legacy of mRNA engineering: A lineup of pioneers for the Nobel Prize.信使核糖核酸工程的传承:诺贝尔奖的先驱阵容。
Mol Ther Nucleic Acids. 2022 Sep 13;29:272-284. doi: 10.1016/j.omtn.2022.07.003. Epub 2022 Jul 13.
6
Oral mRNA Vaccines Against Infectious Diseases- A Bacterial Perspective [Invited].口服 mRNA 疫苗防治传染病:细菌视角 [特邀]。
Front Immunol. 2022 May 3;13:884862. doi: 10.3389/fimmu.2022.884862. eCollection 2022.
7
From the Editor-in-Chief.来自主编
F S Sci. 2021 Feb;2(1):1. doi: 10.1016/j.xfss.2021.01.003. Epub 2021 Jan 11.
8
The infinite possibilities of RNA therapeutics.RNA 疗法的无限可能。
J Ind Microbiol Biotechnol. 2021 Dec 23;48(9-10). doi: 10.1093/jimb/kuab063.
9
Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across.控制常规和自我扩增 mRNA 疗法固有免疫活性的策略:传递信息。
Adv Drug Deliv Rev. 2021 Sep;176:113900. doi: 10.1016/j.addr.2021.113900. Epub 2021 Jul 26.
10
Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists.风湿科医师新加坡分会关于风湿性疾病患者接种 COVID-19 疫苗的建议。
Int J Rheum Dis. 2021 Jun;24(6):746-757. doi: 10.1111/1756-185X.14107. Epub 2021 May 10.